
Applied DNA to Participate in Maxim Group’s COVID-19 Virtual Conference Series on May 27
May 21st, 2020
Applied DNA to Participate in Maxim Group’s COVID-19 Virtual Conference Series on May 27
May 21st, 2020
Colorcon launches on-dose authentication platform for drugs
May 20th, 2020
New Highly Sensitive COVID-19 Clinical Test Now in Use at Stony Brook
May 18th, 2020
FDA grants EUA for COVID-19 molecular tests
May 18th, 2020
APDN Receives FDA Emergency Use Authorization for COVID-19 Diagnostic Assay Kit
May 15th, 2020
Applied DNA Reports 2020 Fiscal Second Quarter Financial Results
May 14th, 2020
Applied DNA launches RT-PCR test for COVID-19
May 14th, 2020
Applied DNA Receives FDA Emergency Use Authorization for COVID-19 Diagnostic Assay Kit
May 14th, 2020
Applied DNA Schedules Fiscal 2020 Second Quarter Financial Results Conference Call for Thursday, May 14, 2020 at 4:30 PM ET
May 7th, 2020